Go to the reading

A question to work through

Does an offer mean MOTS-c is allowed?

Seeing an offer does not establish that a pharmacy has legal permission to make MOTS-c. Ask which rule allows it.

When someone reports a change in the rules, ask for the document that made the change.

There is no approved US medicine

The FDA is the agency that reviews US medicines. As of September 30, 2026, MOTS-c had no US medicine approval. It also had no FDA-approved instructions for its use. A

A pharmacy usually does compounding: making a medicine to order.

Under pharmacy rules reviewed on September 26, 2026, ordinary pharmacies could not legally make medicines from MOTS-c. It did not meet the rules for which ingredients they may use. These are legal rules, not tests of the powder in a bottle. B

Taking back a request did not give permission

Someone had asked the FDA to allow MOTS-c as a pharmacy ingredient, then took that request back. On the FDA page labeled current as of April 22, 2026, that request is shown as withdrawn. C

The people who asked for the ingredient to be allowed took that request back; the FDA did not clear it.

The FDA still displayed its concerns about possible harm beside the MOTS-c entry when checked on September 30, 2026.

A committee meeting did not change the rules

Before the July 2026 committee meeting, FDA staff recommended keeping MOTS-c off a pharmacy ingredient list. That list sets out which ingredients ordinary pharmacies can use when making medicines to order. A

As of September 30, 2026, the FDA had published no official record of the panel's vote on MOTS-c. D

Under the rules reviewed on September 26, 2026, a committee vote gives the FDA advice. It cannot change the pharmacy ingredient list by itself. B

To change the list, the FDA must follow the process for changing a rule. That process lets the public comment.

Ask about the exact product offered

Ask for the current FDA document that supports the offer. Ask which rule allows the pharmacy to use that exact ingredient in the product offered. A headline about a meeting is only a starting point.

Carry this with you

Taking back a request did not give pharmacies permission to make MOTS-c. A committee meeting alone cannot change the ingredient rules.

Check the person offering a care visit

Source notes for this page

A. FDA's written MOTS-c review

FDA staff made this recommendation before the meeting. It was not a final FDA decision about adding MOTS-c to the pharmacy list.

B. FDA's rules for pharmacy ingredients

These rules say which ingredients ordinary pharmacies may use. They also explain how the FDA can change the pharmacy ingredient list.

C. FDA's table of withdrawn requests

The page date is not a date when the request was withdrawn. The FDA gives no withdrawal date for MOTS-c.

D. FDA's advisory meeting page

As of September 30, 2026, the FDA had posted no official record of the committee's vote on MOTS-c. This page cannot tell you how it voted. A vote alone would not give a pharmacy permission to use MOTS-c.